As we classified the CTS patients according to the electrophysiologic severity into mild, moderate, severe groups, the lowest vitamin D levels were observed in patients with severe CTS.
The Bowel Signs and Symptoms and Abdominal Symptoms Scales were each able to significantly differentiate among the moderate and severe groups as defined by patient ratings of their symptom severity (p < 0.05).
Compared with physical and mental component summary scores, the patient-generated symptom severity classification scheme showed robust discrimination between mild and moderate severity (p <0.0001 and p = 0.0009) and between moderate and severe groups (p = 0.0001 and p = 0.012).
Based on clinician-rated severity, there were clear differences between the mild and moderate or severe groups, but not between the moderate and severe COPD groups.
A non-parametric method of comparison (Wilcoxon rank-sum test) was used for comparisons between SIV encephalitis severity groups of macaques (i.e., none and mild versus moderate and severe groups).
The WHODAS-2 global score showed statistically significant differences among severity groups for all pathologies with ES coefficients over 0.7 between mild and severe groups, except for low back pain.
Serum TNF-α levels did not differ between the more severe groups which were defined by the puncture size [14].
The study includes patients from two hospitals, but, as expected, the number of patients in moderate and severe groups was significantly lower than in mild group.
Data were pooled for medium (N = 2) and severe SE (N = 3) groups as qualitative inspection indicated that there was no difference in TSPO binding between the medium and severe groups.
Qualitatively, based on the results of the PET study with two medium and three severe animals, the data indicate that there was no difference between TSPO binding/inflammation between medium and severe groups.
ABO type, and secretor and Lewis status were evaluated in the mild versus severe groups.
